These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 12615637)

  • 1. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
    Confavreux C; Vukusic S; Adeleine P
    Brain; 2003 Apr; 126(Pt 4):770-82. PubMed ID: 12615637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a two-stage disability progression in multiple sclerosis.
    Leray E; Yaouanq J; Le Page E; Coustans M; Laplaud D; Oger J; Edan G
    Brain; 2010 Jul; 133(Pt 7):1900-13. PubMed ID: 20423930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Mikaeloff Y; Edan G; Clanet M; Dubois B; Debouverie M; Brochet B; Lebrun-Frenay C; Pelletier J; Moreau T; Lubetzki C; Vermersch P; Roullet E; Magy L; Tardieu M; Suissa S; Confavreux C;
    N Engl J Med; 2007 Jun; 356(25):2603-13. PubMed ID: 17582070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.
    Scalfari A; Neuhaus A; Degenhardt A; Rice GP; Muraro PA; Daumer M; Ebers GC
    Brain; 2010 Jul; 133(Pt 7):1914-29. PubMed ID: 20534650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of multiple sclerosis in a population-based cohort.
    Debouverie M; Pittion-Vouyovitch S; Louis S; Guillemin F;
    Eur J Neurol; 2008 Sep; 15(9):916-21. PubMed ID: 18637953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course and prognosis in early-onset MS: comparison with adult-onset forms.
    Simone IL; Carrara D; Tortorella C; Liguori M; Lepore V; Pellegrini F; Bellacosa A; Ceccarelli A; Pavone I; Livrea P
    Neurology; 2002 Dec; 59(12):1922-8. PubMed ID: 12499484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
    Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
    Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
    Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
    Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
    Tedeholm H; Skoog B; Lisovskaja V; Runmarker B; Nerman O; Andersen O
    J Neurol; 2015 May; 262(5):1148-63. PubMed ID: 25712541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does cerebrospinal fluid analysis add predictive value to magnetic resonance imaging for long term irreversible disability in patients with early multiple sclerosis?
    Moroso A; Deloire MS; Ruet A; Ouallet JC; Casey R; Brochet B
    J Neurol Sci; 2015 Jul; 354(1-2):51-5. PubMed ID: 25977107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.
    Guillemin F; Baumann C; Epstein J; Kerschen P; Garot T; Mathey G; Debouverie M;
    Neuroepidemiology; 2017; 48(3-4):179-187. PubMed ID: 28793296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of early versus late disability accumulation in primary progressive MS.
    Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.
    Debouverie M; Louis S; Pittion-Vouyovitch S; Roederer T; Vespignani H
    J Neurol; 2007 Oct; 254(10):1370-5. PubMed ID: 17579804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of multiple sclerosis with early onset.
    Ghezzi A; Pozzilli C; Liguori M; Marrosu MG; Milani N; Milanese C; Simone I; Zaffaroni M
    Mult Scler; 2002 Apr; 8(2):115-8. PubMed ID: 11990867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.